We aim for sustainable performance over time to benefit patients, employees, shareholders and society. Solid financial results and maintaining the trust of society underpin our ability to create value.
Annual Social Impact & Sustainability investor event
Meet Novartis Management 2025
November 20, 2025 | London, UK
Agenda (PDF 0.1 MB) | Speaker biographies (PDF 1.3 MB)
Read the press release
CEO presentation and Q&A
Download the presentation (PDF 1.9 MB)
Watch the webcast
Breakout sessions
Download the breakout slides (PDF 0.6 MB)
Watch the webcast
Third quarter results 2025
Investors event calendar
View recent presentations and learn more about upcoming events.
January 12, 2026
J.P. Morgan Healthcare Conference
San Francisco, USA
Environmental, Social and Governance (ESG)
Novartis aims to hold itself to the highest standards of sustainability and ethical business practices. We take bold steps to increase access to medicines, tackle complex global health challenges, and do our part as a responsible corporate citizen.
ESG updates: November 2025 (PDF 0.8 MB) | July 2025 (PDF 0.8 MB) | May 2025 (PDF 0.9 MB) | February 2025 (PDF 1.0 MB)
Latest updates: Social Impact & Sustainability(PDF 2.1 MB) | Impact & Sustainability (PDF 1.9 MB) | Impact & Health Equity (PDF 9.9 MB)
We have created a set of environmental, social and governance indices to signpost where our key disclosures can be found across our publications and channels. Novartis aims to report comprehensively and transparently for all stakeholders concerned with ESG topics.
Stocks
Reporting and transparency hub
Read our regulatory filings; policies, codes and guidelines that govern our activities; and environmental, social and governance (ESG) disclosures.